Pulmonary hypertension is a daunting accompaniment of advanced heart failure. Efforts to safely and consistently lower pulmonary vascular resistance are necessary but fraught with challenges. In this report the authors explore the novel use of sildenafil, an inhibitor of phosphodiesterase-5, in tackling pulmonary hypertension in heart failure. The salutary effects of this agent deserve further study.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/j.1527-5299.2003.02394.x | DOI Listing |
Publication Analysis
Top Keywords
heart failure
12
pulmonary hypertension
8
sildenafil assessment
4
pulmonary
4
assessment pulmonary
4
pulmonary arterial
4
arterial reactivity
4
reactivity heart
4
failure pulmonary
4
hypertension daunting
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!